The invention relates to pharmaceutical compounds which are based on the anti-inflammatory properties of etheric oils selected from the group consisting ofOriganum vulgaris, Thymus vulgaris, Mentha piperita, Thymus serpilum, Satureahortensis, Saturea montana, Saturea subricata, Carum corticum, Thymus zugis,Ocimum gratisimum, Moranda pungtata, Mosla japanoica and Salvia officinalis.Preferably the etheric oils, obtained at the distillation of Origanumvulgaris, Thymus vulgaris and/or Mentha piperita are used. Such pharmaceuticalcompounds, compared to synthetic sulfonamids, antibiotics and cortisones donot create biorecidives in the human body as well as in animal meat and milkand do not contribute to the resistance of microorganism againstpharmaceutical compositions in general. The composition according to theinvention can be used in the treatment of colibacillosis, dermatomycosis,lice, perspiration and fungus on feet, dermatitis, acne and of veterinarydiseases like coccidiosis, mastitis, etc.
